13,105 Synopsys, Inc. $SNPS Shares Bought by Riverbridge Partners LLC

Riverbridge Partners LLC lifted its stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 23.2% in the third quarter, according to its most recent filing with the SEC. The fund owned 69,586 shares of the semiconductor company’s stock after acquiring an additional 13,105 shares during the period. Riverbridge Partners LLC’s holdings in Synopsys were worth $30,266,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Elevation Wealth Partners LLC raised its position in Synopsys by 96.4% during the second quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company’s stock valued at $25,000 after purchasing an additional 27 shares in the last quarter. Osbon Capital Management LLC purchased a new position in shares of Synopsys in the 2nd quarter worth about $25,000. IMG Wealth Management Inc. purchased a new position in shares of Synopsys in the 2nd quarter worth about $28,000. GK Wealth Management LLC bought a new position in shares of Synopsys during the 3rd quarter valued at about $28,000. Finally, EFG International AG bought a new position in shares of Synopsys during the 2nd quarter valued at about $34,000. 85.47% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Synopsys news, CEO Sassine Ghazi sold 14,604 shares of the business’s stock in a transaction that occurred on Tuesday, September 15th. The stock was sold at an average price of $374.88, for a total value of $5,474,747.52. Following the completion of the sale, the chief executive officer owned 76,865 shares in the company, valued at approximately $28,815,151.20. The trade was a 15.97% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Sudhindra Kankanwadi sold 9,170 shares of the firm’s stock in a transaction that occurred on Tuesday, October 6th. The stock was sold at an average price of $500.00, for a total transaction of $4,585,000.00. Following the completion of the transaction, the chief financial officer owned 22,717 shares in the company, valued at $11,358,500. This represents a 28.76% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 117,163 shares of company stock valued at $51,366,457 over the last quarter. Company insiders own 0.56% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on SNPS shares. Robert W. Baird raised Synopsys from a “neutral” rating to an “outperform” rating and raised their price objective for the company from $558.00 to $560.00 in a report on Thursday, August 27th. Sanford C. Bernstein began coverage on Synopsys in a research note on Friday, September 25th. They issued an “outperform” rating for the company. Zacks Research upgraded shares of Synopsys from a “hold” rating to a “strong-buy” rating in a research report on Friday, October 2nd. JPMorgan Chase & Co. decreased their price target on shares of Synopsys from $650.00 to $600.00 in a research note on Thursday, August 27th. Finally, UBS Group set a $570.00 price objective on shares of Synopsys in a report on Thursday, August 27th. One analyst has rated the stock with a Strong Buy rating, twenty-two have issued a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $575.00.

Get Our Latest Report on SNPS

Synopsys Stock Down 1.5%

Shares of NASDAQ:SNPS opened at $459.95 on Wednesday. The stock’s 50-day moving average price is $442.50 and its 200-day moving average price is $441.75. Synopsys, Inc. has a 12-month low of $362.55 and a 12-month high of $539.48. The stock has a market capitalization of $88.14 billion, a P/E ratio of 47.46, a price-to-earnings-growth ratio of 1.48 and a beta of 1.18. The company has a current ratio of 1.34, a quick ratio of 1.24 and a debt-to-equity ratio of 0.29.

Synopsys (NASDAQ:SNPS – Get Free Report) last released its earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share for the quarter, beating analysts’ consensus estimates of $3.67 by $0.24. The company had revenue of $2.48 billion during the quarter, compared to analyst estimates of $2.44 billion. Synopsys had a return on equity of 6.24% and a net margin of 11.43%. Synopsys’s revenue for the quarter was up 42.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $3.39 EPS. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. On average, equities analysts anticipate that Synopsys, Inc. will post 11.01 earnings per share for the current year.

Synopsys declared that its board has initiated a share repurchase plan on Monday, October 5th that permits the company to buy back $1 billion in outstanding shares. This repurchase authorization permits the semiconductor company to repurchase up to 1.1% of its shares through open market purchases. Stock repurchase plans are often a sign that the company’s management believes its shares are undervalued.

Synopsys Profile

(Free Report)

Synopsys, Inc. develops software, semiconductor intellectual property (IP) and services used to design and verify electronic systems. Its electronic design automation (EDA) tools help customers create, simulate, test and validate chips and other complex electronic products, while its IP portfolio provides reusable building blocks for semiconductor designs. The company also offers software security and quality tools that help developers identify vulnerabilities and assess applications throughout the software development process.

Recommended Stories

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.